Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Clinical Investigation|September 7, 2021
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteinsMasami Shimizu-Albergine, Debapriya Basu, Jenny E Kanter, et al.Cell Reports|April 15, 2014
Testing the role of myeloid cell glucose flux in inflammation and atherosclerosisTomohiro Nishizawa, Jenny E Kanter, Farah Kramer, et al.Plos Genetics|May 10, 2008
An inducible and reversible mouse genetic rescue systemHongkui Zeng, Kyoji Horie, Linda Madisen, et al.Circulation Research|June 3, 2024
Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives AtherosclerosisVishal Kothari, Tse W W Ho, Ainara G Cabodevilla, et al.The Journal of Clinical Investigation|July 12, 2019
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetesJenny E Kanter, Baohai Shao, Farah Kramer, et al.Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1Jenny E Kanter, Farah Kramer, Shelley Barnhart, et al.Journal of Lipid Research|December 15, 2024
Type I IFN induces long-chain acyl-CoA synthetase 1 to generate a phosphatidic acid reservoir for lipotoxic saturated fatty acidsShelley Barnhart, Masami Shimizu-Albergine, Eyal Kedar, et al.Research Square|July 25, 2025
Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetesJenny E Kanter, Cheng-Chieh Hsu, Farah Kramer, et al.Pageof 3